+245.8%
THC vs AVAV
+48.2%
+197.6%
-34.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | AVAV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.6% | -1.7% | +2.3% | +0.7% |
| 7D | -0.7% | -2.2% | +1.6% | -0.5% |
| 30D | +1.3% | -13.9% | +15.2% | +2.3% |
| 3M | +64.2% | -29.2% | +93.5% | +67.8% |
| 6M | +8.3% | -36.1% | +44.4% | +11.3% |
| YTD | +33.4% | -40.2% | +73.6% | +35.7% |
| 1Y | +37.7% | -36.2% | +73.9% | +36.9% |
| All | +245.8% | +48.2% | +197.6% | +182.9% |
Cumulative growth
Daily Returns
Daily percentage return beside AVAV.
Daily Out/Under-Performance
Portfolio return minus AVAV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AVAV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded AVAV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling